Molecular Imaging: Page 96

Spatial resolution model enhances PET imaging of various cancers

By Wayne Forrest

Using routine clinical protocols in whole-body FDG-PET/CT, Danish researchers have found that a point spread function PET reconstruction technique increases lesion detection for numerous cancers, according to an article in the European Journal of Radiology.

January 7, 2013

Moving to the dark side: Personalized medicine revisited

By Dr. Peter Rinck, PhD

Swimming with the scientific tide doesn't necessarily mean clinging to progress. In his latest column, Dr. Peter Rinck revisits the topic of personalized medicine, taking a short look back in medicine's history.

January 6, 2013

AuntMinnieEurope.com Molecular Imaging Insider

By Philip Ward

December 9, 2012

MILabs pushes ahead with new Tokyo installation

By AuntMinnieEurope.com staff writers

Dutch molecular imaging developer MILabs said it will install MILabs VECTor/CT at Japan's National Institute of Radiological Sciences in Tokyo.

December 9, 2012

Leiden debate focuses attention on future of imaging markers

By John Bonner

Hundreds of promising target molecules have been identified in preclinical studies for possible use as novel cell imaging agents. But how many are ever likely to be used in real patients? And who will pay the costs of the clinical trials needed to prove their value?

December 9, 2012

The future is hybrid, predicts French visionary

By Frances Rylands-Monk

Radiology is moving more toward modality marriage, as specialists try to harvest optimum imaging yields at best cost-benefit ratios. PET/MRI, a pipe dream in years past, now looks to hold particular promise, with industry embarking on bold research and development programs, according to ECR 2011 President Dr. Yves Menu.

December 4, 2012

Adding a radiologist improves rad therapy treatment planning

By Cynthia E. Keen

CHICAGO - Having a consultant diagnostic radiologist as a member of a radiation oncology treatment planning team can help improve the accuracy and appropriateness of radiotherapy for cancer patients, according to study results presented on Tuesday at the RSNA annual meeting.

November 29, 2012

Never mind the fashion, let's get personal

By Dr. Peter Rinck, PhD

Once again, one of the topics at this week's annual meeting of the RSNA in Chicago will be personalized medicine. It's a term on everyone's lips, yet everyone seems to mean something different.

November 25, 2012

Innovative U.K. center focuses on brain research

By Tami Freeman, PhD

Investigations into the workings of the human brain are being undertaken by scientists from many disciplines. The Cardiff University Brain Research Imaging Centre aims to bring researchers and specialists together to access state-of-the-art brain imaging instruments.

November 22, 2012

PET assists in predicting response to chemotherapy

By Philip Ward

Dutch researchers have used positron emission tomography (PET) to predict how much of an anticancer drug is absorbed by a tumor. In a preliminary study in lung cancer patients reported today in Dublin, they revealed that less than 1% of the drug docetaxel is absorbed by the tumors.

November 7, 2012

Copenhagen's Rigshospitalet installs Biograph mMR system

By AuntMinnieEurope.com staff writers

The Righospitalet of Copenhagen University Hospital has installed a Biograph mMR MR/PET scanner from Siemens Healthcare.

October 23, 2012

EU's CHMP offers positive opinion on Amyvid

By AuntMinnieEurope.com staff writers

Europe's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Amyvid (florebetapir F-18) for injection as a PET radiotracer to detect beta-amyloid neuritic plaque in patients with cognitive impairment, according to Eli Lilly and its subsidiary Avid Radiopharmaceuticals.

October 18, 2012

Previous Page

Page 96 of 122

Next Page